Parp Inhibitors, Cancer Treatment | featured news

New drugs could transform cancer treatment

A new class of drugs called ‘PARP inhibitors’ may be the most exciting development in cancer research in a decade or more: In just a few years, it could save thousands of lives.

 

Subscribe to this RSS topic: Syndicate content